FdaApplication
NDA 020973
Identifiers
- fda_app_no: NDA020973
Properties
| Property | Value |
|---|---|
| applicant_name | WAYLIS THERAPEUTICS LLC |
| application_type | NDA |
| approval_date | 1999-08-19 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ACIPHEX | RABEPRAZOLE SODIUM | 20MG | TABLET, DELAYED RELEASE;ORAL |
| ACIPHEX | RABEPRAZOLE SODIUM | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, DELAYED RELEASE;ORAL |
2 products